Diets high in sugar or fat are associated with multiple health conditions, including binge eating disorder (BED). BED affects approximately 2% of the US adult population, and occurs more frequently in females. It is important to develop animal models of palatable food consumption and food seeking that may have relevance for BED and other conditions associated with excessive food intake. The catecholamine uptake blocker and d-amphetamine prodrug lisdexamfetamine is used to treat BED. The present experiments studied the effect of lisdexamfetamine on food intake and food-reinforced effort-based choice in female Wistar rats. Three groups of rats received different food exposure conditions in the home cage randomly spread over several weeks: a c...
Oleoylethanolamide (OEA), is an endogenous lipid, which, despite its structural and similar biosynth...
Introduction and aim of the studies: Binge eating disorder (BED) is a more recently defined syndrom...
Background: Eating disorders are multifactorial psychiatric disorders. Chronic stressful experiences...
Diets high in sugar or fat are associated with multiple health conditions, including binge eating di...
Binge Eating Disorder (BED) is a psychiatric disorder that is characterized by the consumption of an...
Binge eating disorder (BED) is a psychophysiological disorder defined as the excessive intake of hig...
Lisdexamfetamine dimesylate (LDX) is the only drug currently approved by the FDA for the treatment o...
Binge-eating disorder (BED) is characterized by recurring episodes of excessive consumption of palat...
Binge eating episodes are characterized by uncontrollable, distressing eating of a large amount of h...
Binge-Eating Disorder (BED) is the most common eating disorder in the United States. Lisdexamfetamin...
Binge eating disorder (BED) is the most frequent eating disorder, for which current pharmacothe...
Binge eating disorder (BED) is the most frequent eating disorder, for which current pharmacotherapie...
Eating disorders are multifactorial conditions involving genetic, metabolic, environmental, and beha...
Oleoylethanolamide (OEA), is an endogenous lipid, which, despite its structural and similar biosynth...
Introduction and aim of the studies: Binge eating disorder (BED) is a more recently defined syndrom...
Background: Eating disorders are multifactorial psychiatric disorders. Chronic stressful experiences...
Diets high in sugar or fat are associated with multiple health conditions, including binge eating di...
Binge Eating Disorder (BED) is a psychiatric disorder that is characterized by the consumption of an...
Binge eating disorder (BED) is a psychophysiological disorder defined as the excessive intake of hig...
Lisdexamfetamine dimesylate (LDX) is the only drug currently approved by the FDA for the treatment o...
Binge-eating disorder (BED) is characterized by recurring episodes of excessive consumption of palat...
Binge eating episodes are characterized by uncontrollable, distressing eating of a large amount of h...
Binge-Eating Disorder (BED) is the most common eating disorder in the United States. Lisdexamfetamin...
Binge eating disorder (BED) is the most frequent eating disorder, for which current pharmacothe...
Binge eating disorder (BED) is the most frequent eating disorder, for which current pharmacotherapie...
Eating disorders are multifactorial conditions involving genetic, metabolic, environmental, and beha...
Oleoylethanolamide (OEA), is an endogenous lipid, which, despite its structural and similar biosynth...
Introduction and aim of the studies: Binge eating disorder (BED) is a more recently defined syndrom...
Background: Eating disorders are multifactorial psychiatric disorders. Chronic stressful experiences...